Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Trudeke Van Noord"'
Autor:
Mengalvio E. Sleeswijk, Jaap E. Tulleken, John H. J. M. Meertens, Jan G. Zijlstra, Jack J. M. Ligtenberg, Trudeke Van Noord
Publikováno v:
Journal of Intensive Care Medicine, 23(1), 61-66. BMC
Amiodarone is considered a first-choice antiarrhythmic drug in critically ill patients with new-onset atrial fibrillation (AF). However, evidence supporting the use of this potentially toxic drug in critically ill patients is scarce. Magnesium sulpha
Autor:
Maarten P. van den Berg, Nic J. G. M. Veeger, Isabelle C. Van Gelder, Harry J.G.M. Crijns, Ans C.P. Wiesfeld, Martin E.W. Hemels, Dirk J. van Veldhuisen, Trudeke Van Noord, Hans A. Bosker, Adelita V. Ranchor
Publikováno v:
Journal of the American College of Cardiology, 48(5), 1001-1009. ELSEVIER SCIENCE INC
OBJECTIVES The VERDICT (Verapamil Versus Digoxin and Acute Versus Routine Serial Cardioversion Trial) is a prospective, randomized study to investigate whether: 1) acutely repeated serial electrical cardioversions (ECVs) after a relapse of atrial fib
Autor:
Jaap Haaksma, Harry J.G.M. Crijns, Maarten P. Van Den Berg, Jan Brouwer, Dirk J. Van Veldhuisen, Trudeke Van Noord, Isabelle C. Van Gelder
Publikováno v:
Journal of Cardiovascular Electrophysiology, 15(9), 1027-1033. Wiley
Electrical Cardioversion for Atrial Fibrillation. Introduction: Atrial fibrillation (AF) is characterized by an irregularly irregular ("random") heart beat. However, controversy exists whether the ventricular rhythm in AF is truly random. We investig
Autor:
Harry J.G.M. Crijns, Hans A. Bosker, Isabelle C. Van Gelder, T Kingma, Robert G. Tieleman, Trudeke Van Noord, Dirk J. van Veldhuisen
Publikováno v:
Europace. 6:343-350
Aim Differential drug treatment guided by the underlying heart dis- ease may improve outcome of rhythm control therapy. In the present study we investigated in a well-defined group with either lone atrial fibrillation (AF) or hyper- tension whether t
Publikováno v:
Cardiac Electrophysiology Review. 4:237-239
Autor:
Mengalvio E. Sleeswijk, Trudeke Van Noord, Jaap E. Tulleken, Jan G. Zijlstra, Armand R. J. Girbes, Jack J. M. Ligtenberg
Publikováno v:
Sleeswijk, M E, Van Noord, T, Tulleken, J E, Ligtenberg, J J M, Girbes, A R J & Zijlstra, J G 2007, ' Clinical review : Treatment of new-onset atrial fibrillation in medical intensive care patients: A clinical framework ', Critical Care, vol. 11, no. 6, 233 . https://doi.org/10.1186/cc6136
Critical Care
Critical Care
Atrial fibrillation occurs frequently in medical intensive care unit patients. Most intensivists tend to treat this rhythm disorder because they believe it is detrimental. Whether atrial fibrillation contributes to morbidity and/or mortality and whet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0b559a0868ffa065b26fc31723538b8
https://research.vumc.nl/en/publications/a74cc601-9a39-4aa3-88d4-9ea1cf5d28d0
https://research.vumc.nl/en/publications/a74cc601-9a39-4aa3-88d4-9ea1cf5d28d0
Autor:
Maarten P. van den Berg, Harry J.G.M. Crijns, Dirk J. van Veldhuisen, Trudeke Van Noord, Isabelle C. Van Gelder
Publikováno v:
BMC Cardiovascular Disorders
BMC Cardiovascular Disorders, Vol 5, Iss 1, p 3 (2005)
BMC Cardiovascular Disorders, Vol 5, Iss 1, p 3 (2005)
Background Persistent atrial fibrillation (AF) is difficult to treat. In the absence of class I or III antiarrhythmic drugs sinus rhythm is maintained in only 30% of patients during the first year after electrical cardioversion (ECV). One of the remo
Autor:
Trudeke, Van Noord, Robert G, Tieleman, Hans A, Bosker, Tsjerk, Kingma, Dirk J, Van Veldhuisen, Harry J G M, Crijns, Isabelle C, Van Gelder
Publikováno v:
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 6(4)
Differential drug treatment guided by the underlying heart disease may improve outcome of rhythm control therapy. In the present study we investigated in a well-defined group with either lone atrial fibrillation (AF) or hypertension whether there wer
Publikováno v:
Journal of Cardiovascular Electrophysiology, 13(8), 822-825. Wiley
Electrical Cardioversion. Introduction: In almost 20% of patients with persistent atrial fibrillation (AF), electrical cardioversion is unsuccessful because of shock failure (i.e., no single sinus beat) or immediate reinitiation of AF (IRAF; recurren
Publikováno v:
Chest, 136(2), 651-652. ELSEVIER SCIENCE BV
2009;136;651-652 Chest G. Zijlstra Mengalvio Sleeswijk, Trudeke van Noord, Jack J. M. Ligtenberg and Jan Acute Management of Atrial Fibrillation http://chestjournal.chestpubs.org/content/136/2/651.full.html services can be found online on the World W